JasonLVassyMDMPH, MS

Clinician-investigator

Dr. Vassy is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Jason Vassy, MD, MPH, MS is an Internal Medicine specialist based in Boston, MA, with a comprehensive education background that includes a Residency at the University of Pennsylvania Health System and a Fellowship at Massachusetts General Hospital. Dr. Vassy is associated with Veterans Affairs Boston Healthcare System - Jamaica Plain, Brigham and Women's Hospital, and Harvard Medical School. His contributions to medical literature are significant, showcasing a variety of studies on subjects like genetic risk scores and body mass index variability. Notably active in clinical research, he has had key roles in several trials including the Genomic Medicine at VA Study and the Million Veteran Program Return of Actionable Results.

Massachusetts General HospitalFellowship, Internal Medicine, 2010 - 2012
University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
Washington University in St. Louis School of MedicineClass of 2007

Integrating Pharmacogenetics In Clinical Care Start of enrollment: 2016 Aug 01
Completed
Not Applicable
The VetSeq Study: a Pilot Study of Genome Sequencing in Veteran Care Start of enrollment: 2017 Dec 29
Completed
Not Applicable
Million Veteran Program Return of Actionable Results Start of enrollment: 2019 Dec 30
Enrolling by invitation
Not Applicable
The Genomic Medicine at VA Study Start of enrollment: 2020 Jul 17
Recruiting
Not Applicable
Roles: Principal Investigator
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) Start of enrollment: 2024 Feb 01
Recruiting
Not Applicable
Join now to see all

PubMed

Reframing SDM Using Implementation Science: SDM Is the Intervention.
Marla L Clayman, A Rani Elwy, Jason L Vassy
Medical Decision Making. 2024-11-01
4 citations
Healthy lifestyle and prostate cancer risk in the Million Veteran Program.
Meghana S Pagadala, Asona Lui, Julie Lynch, Roshan Karunamuni, Kyung Min Lee
Cancer. 2024-10-15
Design and pilot results from the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study.
Jason L Vassy, Charles A Brunette, Thomas Yi, Alicia Harrison, Mark P Cardellino
American Heart Journal. 2024-10-01

Journal Articles

Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older
Jane A Driver, Jason L Vassy, J Michael Gaziano, JAMA
Secondary Findings from Clinical Genomic Sequencing: Prevalence, Patient Perspectives, Family History Assessment, and Health-Care Costs from a Multisite Study
Kyle B Brothers, Joel B Krier, Benjamin S Wilfond, Jonathan S Berg, Laura M Amendola, Sharon E Plon, Jason L Vassy, Gail P Jarvik, Heidi L Rehm, Robert C Green, Nature
Pharmacogenetic Testing in the Veterans Health Administration (VHA): Policy Recommendations from the VHA Clinical Pharmacogenetics Subcommittee
Jason L Vassy, Steven A Schichman, John T Callaghan, Nature

Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Association of Statin Use with All-Cause and Cardiovascular Mortality in US Veterans 75 Years and OlderJuly 2020
Join now to see all

NIH Awards 5.4 Million for Genomics Integration in Learning Health SystemsSeptember 22nd, 2024
Scientists Use Thousands of Genetic Markers to Develop Risk Scores for Six Common Diseases: Findings May Have Implications for Clinical LaboratoriesMay 25th, 2022
Genetic Test for Six Chronic Diseases Undergoing Clinical TrialApril 29th, 2022
Join now to see all